Morana Jovan-Embiricos - 10%+ Owner at Cullinan Therapeutics, Inc.

Issuer-level insider activity

Role: 10%+ Owner
Issuer ticker: CGEM on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Morana Jovan-Embiricos since 10 Sep 2025

Reported holdings for Morana Jovan-Embiricos in Cullinan Therapeutics, Inc.

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 1,305,873
Estimated value: $16,271,178
Report date: 24 Jun 2022
Price: $12.46
Ownership: By F2 Vision SCS

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 1,136,525
Estimated value: $14,161,102
Report date: 24 Jun 2022
Price: $12.46
Ownership: By Globeways Holdings Ltd.

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 622,175
Estimated value: $7,752,301
Report date: 24 Jun 2022
Price: $12.46
Ownership: By F2-TPO Investments, LLC

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 537,392
Estimated value: $6,695,904
Report date: 24 Jun 2022
Price: $12.46
Ownership: By F2 Bioscience I 2017 Ltd.

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 325,333
Estimated value: $4,053,649
Report date: 24 Jun 2022
Price: $12.46
Ownership: By F2 MG Ltd.

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 214,798
Estimated value: $2,676,383
Report date: 24 Jun 2022
Price: $12.46
Ownership: By F2 MC, LLC

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 207,803
Estimated value: $2,589,225
Report date: 24 Jun 2022
Price: $12.46
Ownership: Direct

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 104,762
Estimated value: $1,305,335
Report date: 24 Jun 2022
Price: $12.46
Ownership: By F2 GC, LLC

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Common Stock
Shares / value: 71,599
Estimated value: $892,124
Report date: 24 Jun 2022
Price: $12.46
Ownership: By F2 Bio TD, LLC

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 0
Estimated value
Report date: 24 Jun 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Morana Jovan-Embiricos in Cullinan Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .